173 related articles for article (PubMed ID: 38711981)
1. Overweight as a biomarker for concomitant thyroid cancer in patients with Graves' disease.
Park J; An S; Bae JS; Kim JS; Kim K
Front Endocrinol (Lausanne); 2024; 15():1382124. PubMed ID: 38711981
[TBL] [Abstract][Full Text] [Related]
2. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
Carnell NE; Valente WA
Thyroid; 1998 Aug; 8(8):647-52. PubMed ID: 9737358
[TBL] [Abstract][Full Text] [Related]
3. Thyroid nodules in Graves' disease: classification, characterization, and response to treatment.
Carnell NE; Valente WA
Thyroid; 1998 Jul; 8(7):571-6. PubMed ID: 9709909
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease?
Tamatea JA; Tu'akoi K; Conaglen JV; Elston MS; Meyer-Rochow GY
ANZ J Surg; 2014 Apr; 84(4):231-4. PubMed ID: 22985335
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of thyroid cancer in patients with Graves' disease.
Ren M; Wu MC; Shang CZ; Wang XY; Zhang JL; Cheng H; Xu MT; Yan L
World J Surg; 2014 Jan; 38(1):80-7. PubMed ID: 24166025
[TBL] [Abstract][Full Text] [Related]
6. Multicentre study of thyroid nodules in patients with Graves' disease.
Kraimps JL; Bouin-Pineau MH; Mathonnet M; De Calan L; Ronceray J; Visset J; Marechaud R; Barbier J
Br J Surg; 2000 Aug; 87(8):1111-3. PubMed ID: 10931060
[TBL] [Abstract][Full Text] [Related]
7. Postoperative Outcomes in Graves' Disease Patients: Results from the Nationwide Inpatient Sample Database.
Rubio GA; Koru-Sengul T; Vaghaiwalla TM; Parikh PP; Farra JC; Lew JI
Thyroid; 2017 Jun; 27(6):825-831. PubMed ID: 28457178
[TBL] [Abstract][Full Text] [Related]
8. Graves' disease and thyroid cancer.
Behar R; Arganini M; Wu TC; McCormick M; Straus FH; DeGroot LJ; Kaplan EL
Surgery; 1986 Dec; 100(6):1121-7. PubMed ID: 3787468
[TBL] [Abstract][Full Text] [Related]
9. Thyroid surgery for Graves' disease and Graves' ophthalmopathy.
Liu ZW; Masterson L; Fish B; Jani P; Chatterjee K
Cochrane Database Syst Rev; 2015 Nov; (11):CD010576. PubMed ID: 26606533
[TBL] [Abstract][Full Text] [Related]
10. Increased aggressiveness of thyroid cancer in patients with Graves' disease.
Belfiore A; Garofalo MR; Giuffrida D; Runello F; Filetti S; Fiumara A; Ippolito O; Vigneri R
J Clin Endocrinol Metab; 1990 Apr; 70(4):830-5. PubMed ID: 2180978
[TBL] [Abstract][Full Text] [Related]
11. Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
Jin M; Jang A; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
PLoS One; 2022; 17(3):e0265332. PubMed ID: 35275968
[TBL] [Abstract][Full Text] [Related]
12. [Thyroid nodules associated with Graves' disease: another argument for surgical treatment].
Kraimps JL; Bouin-Pineau MH; Maréchaud R; Barbier J
Chirurgie; 1997; 122(8-9):488-90. PubMed ID: 9616893
[TBL] [Abstract][Full Text] [Related]
13. Coexistent thyroid nodules in patients with graves' disease: What is the frequency and the risk of malignancy?
Shi HH; McHenry CR
Am J Surg; 2018 Nov; 216(5):980-984. PubMed ID: 30049435
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of small thyroid cancer in patients with Graves' disease.
Kikuchi S; Noguchi S; Yamashita H; Uchino S; Kawamoto H
Br J Surg; 2006 Apr; 93(4):434-9. PubMed ID: 16523447
[TBL] [Abstract][Full Text] [Related]
15. Thyroid cancer yield in patients with Graves' disease.
Stocker DJ; Burch HB
Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
[TBL] [Abstract][Full Text] [Related]
16. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer.
Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J
J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381
[TBL] [Abstract][Full Text] [Related]
17. Thyroid carcinoma in Graves' disease.
Ozaki O; Ito K; Kobayashi K; Toshima K; Iwasaki H; Yashiro T
World J Surg; 1990; 14(3):437-40; discussion 440-1. PubMed ID: 2368449
[TBL] [Abstract][Full Text] [Related]
18. Poorly Differentiated Thyroid Carcinoma Coexisting with Graves' Disease Involving T3 Thyrotoxicosis due to Increased D1 and D2 Activities.
Okazaki-Hada M; Maruoka A; Yamamoto M; Ito M; Hirokawa M; Nishikawa M; Akamizu T; Miyauchi A; Toyoda N
Thyroid; 2021 Oct; 31(10):1592-1596. PubMed ID: 34278816
[No Abstract] [Full Text] [Related]
19. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
20. Patient-Reported Outcomes Following Total Thyroidectomy for Graves' Disease.
Gunn AH; Frisco N; Thomas SM; Stang MT; Scheri RP; Kazaure HS
Thyroid; 2022 Jan; 32(1):54-64. PubMed ID: 34663089
[No Abstract] [Full Text] [Related]
[Next] [New Search]
